BeiGene raises $158.4 mln in second U.S. IPO to price in 2016
February 02, 2016 at 20:40 PM EST
Feb 2 (Reuters) - Chinese immunotherapy company BeiGene Ltd became the second company to price an initial public offering in the United States in 2016 on Tuesday, raising $158.4 million, according to a person familiar with the matter.
